生物-Gene和Envu伙伴评估用于蚊虫管理的同质生物杀虫剂FlavocideTM,处理杀虫剂抗药性和疟疾、登革热和Zika等疾病。 Bio-Gene and Envu partner to evaluate nature-identical bio-insecticide Flavocide™ for mosquito management, addressing insecticide resistance and diseases like Malaria, Dengue fever, and Zika.

生物-基因和Envu伙伴评估FlavocideTM,这是一种性质相同的生物杀虫剂,用于公共和私营部门的蚊子管理。 Bio-Gene and Envu partner to evaluate Flavocide™, a nature-identical bio-insecticide, for public and private sector mosquito management. Flavoficide从植物化合物Flavesone衍生而来,解决杀虫剂抗药性问题,防治疟疾、登革热和Zika病毒等疾病。 Derived from Flavesone, a plant compound, Flavocide addresses insecticide resistance and targets diseases like Malaria, Dengue fever, and Zika virus. 合作的目的是制定更安全、有效的蚊子管理解决方案,以减少疾病流行,特别是在儿童死亡率高的地区。 The collaboration aims to create safer, effective mosquito management solutions to reduce disease prevalence, particularly in regions with high child mortality rates.